Dabigatran (Pradaxa(®)): surgeon's friend or foe?
All clinicians, whether in primary or secondary care settings, are likely to encounter patients on this new anticoagulant. Therefore, it is imperative that clinicians are aware of the risks and benefits associated with dabigatran.